Kimia Farma (Persero) Tbk PT operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kimia Farma (Persero) Tbk PT with three other
pharmaceutical manufacturers in Asia:
Shandong Lukang Pharmaceutical
sales of 2.21 billion Chinese Renmimbi [US$361.16 million]
Zhejiang Jianfeng Group Company Limited
(2.15 billion Chinese Renmimbi [US$351.50 million]
of which 44%
was Cement/Construction Materials), and
PKU HealthCare Corp Ltd
based in China
(2.32 billion Chinese Renmimbi [US$378.50 million]
of which 55%
was Medicine Production).
Kimia Farma (Persero) Tbk PT reported sales of 4.35 trillion Indonesian Rupiahs (US$357.85 million)
December of 2013.
increase of 16.4%
versus 2012, when the company's sales were 3.73 trillion Indonesian Rupiahs.
Sales at Kimia Farma (Persero) Tbk PT have increased during each of the previous five years
(and since 2008, sales have increased a total of 61%).
Sales of Distribution saw an increase
20.3% in 2013, from
1.61 trillion Indonesian Rupiahs to 1.94 trillion Indonesian Rupiahs.
Not all segments of Kimia Farma (Persero) Tbk PT experienced an increase in sales in 2013:
sales of Manufacturing fell 22.7% to 153.56 billion Indonesian Rupiahs.